EQA Catalogue Groups
(Click on a colour/icon to filter calendar entries)
Clinical Genetics and Genetic Counselling
Genomic and Inherited Disorders
Haematological Neoplasms
Individual Competency Assessment
Molecular Newborn Screening
Molecular Pathology
Multidisciplinary team (MDT) working
Pharmacogenomics
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Sample Handling
Technical (NGS and OGM)
Variant Classification and Nomenclature
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Conference
GenQA workshop
GenQA Participant meeting
GenQA office closed
Other
«prev June 2025 next»
| ||||||
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
Sun 1 | Mon 2
Distribution 8 OPEN
2025 Cystic Fibrosis (CF) and CFTR-related disorders - OPENS Testing Period: 7 weeks
2025 Fragile X syndrome and FMR1-related disorders - OPENS Testing Period: 7 weeks
2025 Huntington disease (HD) and DRPLA - OPENS Testing Period: 7 weeks
2025 Trio Sequencing - Postnatal (neonatal and paediatric) - OPENS Testing Period: 18 weeks
2025 X-inactivation - OPENS Testing Period: 7 weeks
2025 Trio Sequencing - Prenatal - OPENS Testing Period: 18 weeks
2025 SARS-CoV-2 sequencing - Distribution 5845 - OPENS Testing Period: 6 weeks from sample distribution | Tue 3 | Wed 4 | Thu 5 | Fri 6 | Sat 7 |
Sun 8 | Mon 9 Join GenQA’s in-person workshop in Belfast on Monday 9th June 2025 to explore best practices in genomic diagnostics and ISO compliance. CPD certificate included.
Distribution 9 OPEN
2025 Preimplantation genetic testing (PGT) of blastomere (FISH) - OPENS Testing Period: 3 weeks for Stage 1; 4 weeks for Stage 2 | Tue 10 | Wed 11 | Thu 12 Prof Sandi Deans, Director of GenQA, will be presenting on “GenQA supporting streamlining genomic data analysis.”
2024 Optical Genome Mapping (OGM) (pilot) - CLOSES | Fri 13 | Sat 14 |
Sun 15 | Mon 16
Distribution 10 OPEN
2025 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks
2025 MCADD Molecular Newborn Screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks
2025 SCID Molecular Newborn Screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks
2025 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) round 2 - OPENS Testing Period: 4 weeks
2025 DNA extraction from blood for long read sequencing (LRS) (pilot) - OPENS Testing Period: 3 Weeks
2025 DNA extraction from venous blood - OPENS Testing Period: 3 Weeks | Tue 17
Distribution 11 OPEN
2025 DNA extraction from fresh tissue - OPENS Testing Period: 3 weeks | Wed 18 | Thu 19 | Fri 20 | Sat 21 |
Sun 22 | Mon 23 | Tue 24 | Wed 25 Discussion of
results from
Run 14
assessment | Thu 26 | Fri 27
2025 Clinical Genetics - dysmorphology - CLOSES
2025 Genetic Counselling - oncogenetics (pilot) - CLOSES
2025 Genetic Counselling - rare and inherited disorders (pilot) - CLOSES
2025 Acute Lymphoblastic Leukaemia (ALL) - CLOSES
2025 Haematological Technical FISH - CLOSES
2025 Myeloid disorders - CLOSES
2025 Myeloma - CLOSES
2025 Microdeletion syndromes - CLOSES
2025 Postnatal karyotyping - CLOSES | Sat 28 |
Sun 29 | Mon 30
2025 cfDNA extraction from plasma - somatic (pilot) - OPENS Testing Period: 3 Weeks | Tue 1 | Wed 2 | Thu 3 | Fri 4
2025 DNA extraction from blood for long read sequencing (LRS) (pilot) - CLOSES
2025 DNA extraction from venous blood - CLOSES
2025 ISCN (International System for Human Cytogenomic Nomenclature) (pilot) - CLOSES
2025 Preimplantation genetic testing (PGT) of blastomere (FISH) - CLOSES | Sat 5 |
NEWSLETTER SIGN UP